Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0S7ZU
|
|||
Former ID |
DNC012634
|
|||
Drug Name |
4-Biphenyl-4-yl-2-methyl-1H-imidazole
|
|||
Synonyms |
CHEMBL330800; SCHEMBL3669956
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C16H14N2
|
|||
Canonical SMILES |
CC1=NC=C(N1)C2=CC=C(C=C2)C3=CC=CC=C3
|
|||
InChI |
1S/C16H14N2/c1-12-17-11-16(18-12)15-9-7-14(8-10-15)13-5-3-2-4-6-13/h2-11H,1H3,(H,17,18)
|
|||
InChIKey |
MBBDOQNKURHTFH-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sodium channel unspecific (NaC) | Target Info | Inhibitor | [1] |
Voltage-gated sodium channel alpha Nav1.3 (SCN3A) | Target Info | Inhibitor | [1] | |
KEGG Pathway | Dopaminergic synapse | |||
Reactome | Interaction between L1 and Ankyrins |
References | Top | |||
---|---|---|---|---|
REF 1 | 2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators. Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.